RxNorm Semantic Concepts Index - 131
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "131".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1310000 | Picea abies flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310001 | Hieracium pilosella flowering top | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310002 | Hippomane mancinella fruiting leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310003 | Viscum album leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310004 | Prunus persica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310005 | Plantago major leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310006 | Bromus ramosus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310007 | Aralia hispida root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310008 | Hibiscus rosa-sinensis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310009 | Prunus persica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310011 | Rosa moschata seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310013 | Dalbergia pinnata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310014 | Mandragora officinarum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310015 | Ruehssia cundurango bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310015 | Ruehssia cundurango bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310016 | Rosa damascena flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310017 | Prunus laurocerasus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310018 | Anamirta cocculus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310019 | Prunus persica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310021 | Crataegus monogyna flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310022 | Styphnolobium japonicum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310023 | Vincetoxicum hirundinaria leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310023 | Vincetoxicum hirundinaria leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310024 | Comocladia dentata bark-leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310025 | Castanea sative leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310027 | camphor 0.031 MG/MG / menthol 0.16 MG/MG / methyl salicylate 0.1 MG/MG [Flexall Ultra Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310028 | Flexall Plus 3.1 % / 16 % / 10 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310028 | Flexall Plus 3.1 % / 16 % / 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310028 | Flexall Plus 3.1 % / 16 % / 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310029 | Senna alexandrina seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310030 | Spanish thyme oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310031 | Nerium oleander leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310032 | Turnera diffusa leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310033 | Pimpinella saxifraga root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310034 | Magnolia liliiflora flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310035 | Solanum dulcamara stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310036 | Tsuga canadensis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310037 | Prunus serrulata flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310038 | lactose, x-ray exposed (1000 rad) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310039 | Trifolium pratense flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310040 | millet extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310041 | Citrus junos seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310042 | Toxicodendron diversilobum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310043 | Cicuta virosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310044 | cashew oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310045 | Larix decidua flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310046 | sesame seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310047 | Nelumbo nucifera flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310048 | Helichrysum italicum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310049 | Peumus boldus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310050 | Stillingia sylvatica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310051 | Solanum dulcamara flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310052 | Nymphaea odorata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310054 | camphor 3.1 % / menthol 1.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310054 | camphor 3.1 % / menthol 1.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310054 | camphor 3.1 % / menthol 1.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310055 | Morus alba root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310056 | Jacaranda caroba flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310057 | Teucrium scorodonia flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310058 | Reversion Acne Control Toner | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310059 | salicylic acid 20 MG/ML [Reversion Acne Control Toner] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310060 | salicylic acid Topical Solution [Reversion Acne Control Toner] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310061 | Reversion Acne Control Toner Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310062 | re:version ACNE CONTROL Toner 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310062 | re:version ACNE CONTROL Toner 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310062 | re:version ACNE CONTROL Toner 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310062 | re:version ACNE CONTROL Toner 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310063 | Frangula alnus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310064 | Citrus sinensis fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310065 | Rheum officinale root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310066 | Matricaria chamomilla leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310066 | Matricaria chamomilla leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310067 | Punica granatum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310068 | Trichosanthes cucumerina seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310069 | Hypoxis hemerocallidea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310070 | European white birch tar oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310070 | European white birch tar oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310071 | Aconitum carmichaelii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310072 | Cuscuta chinensis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310073 | Salix alba flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310075 | Dipsacus asper root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310076 | Calabar bean seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310076 | Calabar bean seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310078 | Justicia gendarussa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310079 | Lespedeza capitata flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310080 | Plantago major seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310081 | Pilocarpus jaborandi leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310082 | Trichosanthes kirilowii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310083 | Eleutherococcus nodiflorus root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310084 | Pinus sylvestris flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310085 | Entada phaseoloides leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310087 | Polygala senega root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310088 | Rhaphiolepis bibas leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310088 | Rhaphiolepis bibas leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310091 | Syzygium cumini seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310092 | Hippophae rhamnoides fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310093 | Haberlea rhodopensis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310094 | Lophatherum gracile leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310095 | Pinus sylvestris leafy twig | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310096 | Rubus chamaemorus seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310097 | lovage oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310098 | galanga root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310098 | galanga root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310099 | Podophyllum peltatum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310100 | Populus tremula flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310101 | Paeonia officinalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310102 | redtop top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310102 | redtop top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310102 | redtop top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310103 | Trillium erectum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310105 | Citrus bergamia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310106 | Populus tremuloides bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310107 | Pinus densiflora bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310108 | Populus tremuloides leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310110 | Scleranthus annuus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310111 | Amanita muscaria var. muscaria fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310112 | Sempervivum tectorum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310113 | Paulownia tomentosa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310114 | Balanites roxburghii seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310115 | ornithogalum umbellatum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310117 | Citrus aurantiifolia flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310119 | Myosotis sylvatica flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310120 | Berberis vulgaris root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310121 | cesium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310122 | chlorine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310123 | F - Fluorine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310123 | F - Fluorine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310123 | F - Fluorine | Designated preferred name (PT) | NO | |
| RxCUI: 1310123 | F - Fluorine | Full form of descriptor (FN) | NO | |
| RxCUI: 1310123 | F - Fluorine | Designated preferred name (PT) | NO | |
| RxCUI: 1310123 | F - Fluorine | Full form of descriptor (FN) | NO | |
| RxCUI: 1310124 | gallium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310125 | dimethicone 1.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310125 | dimethicone 1.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310125 | dimethicone 1.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310126 | Bacopa monniera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310127 | Citrus paradisi fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310128 | Coffea arabica seed, roasted, allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310128 | Coffea arabica seed, roasted, allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310128 | Coffea arabica seed, roasted, allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310129 | dimethicone Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1310130 | dimethicone 4 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310130 | dimethicone 4 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310130 | dimethicone 4 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310131 | Viscum album fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310133 | Onosmodium virginianum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310134 | Elymus repens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310137 | Afinitor Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1310138 | AFINITOR DISPERZ 2 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310138 | AFINITOR DISPERZ 2 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310138 | AFINITOR DISPERZ 2 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310140 | Glechoma hederacea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310141 | Epimedium grandiflorum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310144 | AFINITOR DISPERZ 3 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310144 | AFINITOR DISPERZ 3 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310144 | AFINITOR DISPERZ 3 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310147 | AFINITOR DISPERZ 5 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310147 | AFINITOR DISPERZ 5 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310147 | AFINITOR DISPERZ 5 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310148 | Wyethia helenioides root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310150 | Papaver rhoeas flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310151 | Symphytum tuberosum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310152 | Dactylis glomerata top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310154 | Syzygium jambos seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310155 | Zanthoxylum americanum bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310157 | Jateorhiza calumba root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310159 | Juglans regia flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310161 | Juniperus sabina leaf | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310162 | Chrysanthellum indicum subsp. afroamericanum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310163 | Kalmia angustifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310164 | Centella asiatica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310164 | Centella asiatica whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310164 | Centella asiatica whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310166 | Pelargonium sidoides root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310167 | Handroanthus impetiginosus bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310167 | Handroanthus impetiginosus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310168 | quassia | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310168 | quassia | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310171 | gadolinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310173 | Rhus glabra top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310179 | Vicodin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310183 | curly dock top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310183 | curly dock top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310185 | strychnine nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310187 | Lithium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310187 | Lithium bromide | Designated preferred name (PT) | NO | |
| RxCUI: 1310187 | Lithium bromide | Full form of descriptor (FN) | NO | |
| RxCUI: 1310189 | Juniperus communis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131019 | 11-oxopregnanetriol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131019 | 11-oxopregnanetriol | Designated preferred name (PT) | NO | |
| RxCUI: 131019 | 11-oxopregnanetriol | Full form of descriptor (FN) | NO | |
| RxCUI: 1310190 | Ammonium carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310190 | Ammonium carbonate | Designated preferred name (PT) | YES | |
| RxCUI: 1310190 | Ammonium carbonate | Full form of descriptor (FN) | YES | |
| RxCUI: 1310193 | mercurius solubilis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310197 | acetaminophen 300 MG / hydrocodone bitartrate 5 MG [Vicodin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310197 | acetaminophen 300 MG / hydrocodone bitartrate 5 MG [Vicodin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 131020 | 18-hydroxy-corticosteroid | Designated preferred name (PT) | NO | |
| RxCUI: 131020 | 18-hydroxy-corticosteroid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131020 | 18-hydroxy-corticosteroid | Full form of descriptor (FN) | NO | |
| RxCUI: 1310200 | Vicodin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310202 | Vicodin 5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310203 | Rhododendron tomentosum leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310203 | Rhododendron tomentosum leafy twig extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310208 | acetaminophen 300 MG / hydrocodone bitartrate 7.5 MG [Vicodin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310208 | acetaminophen 300 MG / hydrocodone bitartrate 7.5 MG [Vicodin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310212 | Vicodin ES 7.5 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310213 | American elderberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310215 | Ruta graveolens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310216 | black widow spider preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310217 | Solanum nigrum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310220 | Aconitum napellus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310220 | Aconitum napellus whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310227 | Piper cubeba fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310229 | Ecballium elaterium fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310235 | Spigelia anthelmia whole preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310235 | Spigelia anthelmia whole preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310238 | bovine achilles tendon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310238 | bovine achilles tendon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310241 | water 990 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310244 | bovine adrenal gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310244 | bovine adrenal gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310246 | bovine ankle joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310246 | bovine ankle joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310248 | Berberis vulgaris fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310249 | bovine bile preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310249 | bovine bile preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310249 | bovine bile preparation | Designated preferred name (PT) | NO | |
| RxCUI: 1310249 | bovine bile preparation | Full form of descriptor (FN) | NO | |
| RxCUI: 1310251 | bovine cartilage preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310251 | bovine cartilage preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310252 | beryllium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310253 | bovine colostrum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310253 | bovine colostrum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310255 | bovine frontal lobe preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310255 | bovine frontal lobe preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310256 | bovine gallbladder preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310256 | bovine gallbladder preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310258 | bovine hip joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310258 | bovine hip joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310259 | Crataegus laevigata fruit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310260 | bovine hippocampus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310260 | bovine hippocampus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310261 | bovine hypothalamus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310261 | bovine hypothalamus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310262 | bovine knee joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310262 | bovine knee joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310263 | bovine limbic system preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310263 | bovine limbic system preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310264 | bovine lymph preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310264 | bovine lymph preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310265 | bovine mesenchyme preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310265 | bovine mesenchyme preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310266 | Anemone nemorosa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310267 | bovine nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310267 | bovine nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310268 | acetaminophen 300 MG / hydrocodone bitartrate 10 MG [Vicodin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310268 | acetaminophen 300 MG / hydrocodone bitartrate 10 MG [Vicodin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310270 | Vicodin HP 10 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310273 | bovine ovary preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310273 | bovine ovary preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310275 | bovine pancreas preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310275 | bovine pancreas preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310276 | Virola sebifera resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310279 | Polygonum aviculare top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310280 | Acorus calamus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310281 | Scomberomorus cavalla extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310282 | Trillium erectum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310285 | Gaultheria procumbens top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310287 | Luffa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310287 | Luffa extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310288 | Chaenomeles speciosa fruit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310289 | bovine parathyroid gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310289 | bovine parathyroid gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131029 | Actin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131029 | Actin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310290 | bovine pineal gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310290 | bovine pineal gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310291 | bovine pituitary gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310291 | bovine pituitary gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310292 | bovine erythrocyte preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310292 | bovine erythrocyte preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310293 | bovine solar plexus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310293 | bovine solar plexus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310294 | bovine spinal cord preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310294 | bovine spinal cord preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310295 | bovine spleen preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310295 | bovine spleen preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310296 | bovine sympathetic nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310296 | bovine sympathetic nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310297 | bovine tendon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310297 | bovine tendon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310298 | bovine testicle preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310298 | bovine testicle preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310299 | bovine tonsil preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310299 | bovine tonsil preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131030 | Actinomyces species antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131030 | Actinomyces species antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1310300 | Co - Cobalt | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310300 | Co - Cobalt | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310300 | Co - Cobalt | Designated preferred name (PT) | NO | |
| RxCUI: 1310300 | Co - Cobalt | Full form of descriptor (FN) | NO | |
| RxCUI: 1310300 | Co - Cobalt | Designated preferred name (PT) | NO | |
| RxCUI: 1310300 | Co - Cobalt | Full form of descriptor (FN) | NO | |
| RxCUI: 1310339 | Cyclamen purpurascens tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310350 | Datura stramonium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310367 | Euphorbia resinifera resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131037 | Alpha lactalbumin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131037 | Alpha lactalbumin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131038 | Alpha>1< antichymotrypsin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131038 | Alpha>1< antichymotrypsin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 131039 | Alpha>1< antitrypsin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131039 | Alpha>1< antitrypsin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Full form of descriptor (FN) | NO | |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Designated preferred name (PT) | NO | |
| RxCUI: 1310455 | Agkistrodon contortrix venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310456 | Crotalus horridus horridus venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310457 | Heloderma horridum venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310458 | Lachesis muta venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310459 | Latrodectus mactans venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310459 | Latrodectus mactans venom | Designated preferred name (PT) | NO | |
| RxCUI: 1310459 | Latrodectus mactans venom | Full form of descriptor (FN) | NO | |
| RxCUI: 1310459 | Latrodectus mactans venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310460 | Micrurus corallinus venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310461 | Naja naja venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310462 | Common European adder venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310462 | Common European adder venom | Designated preferred name (PT) | NO | |
| RxCUI: 1310462 | Common European adder venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310462 | Common European adder venom | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310462 | Common European adder venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310462 | Common European adder venom | Full form of descriptor (FN) | NO | |
| RxCUI: 1310463 | calcium phosphate, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310465 | calcium sulfate, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310466 | calcium sulfate, hemihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310467 | creatine monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310469 | dehydrated alcohol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310470 | disodium edetate hydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310472 | benzalkonium chloride 4.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310473 | benzalkonium chloride 0.47 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310473 | benzalkonium chloride 0.47 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310473 | benzalkonium chloride 0.47 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310475 | diphenhydrAMINE HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310475 | diphenhydrAMINE HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310475 | diphenhydrAMINE HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310476 | Vetadryl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310477 | diphenhydramine hydrochloride 10 MG [Vetadryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310477 | diphenhydramine hydrochloride 10 MG [Vetadryl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310478 | diphenhydrAMINE Oral Tablet [Vetadryl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310478 | diphenhydrAMINE Oral Tablet [Vetadryl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310479 | Vetadryl Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310480 | Vetadryl Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310481 | Vetadryl 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310481 | Vetadryl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310481 | Vetadryl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310481 | Vetadryl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310482 | diphenhydramine hydrochloride 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310482 | diphenhydramine hydrochloride 30 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310483 | diphenhydrAMINE HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310483 | diphenhydrAMINE HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310483 | diphenhydrAMINE HCl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310484 | diphenhydramine hydrochloride 30 MG [Vetadryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310484 | diphenhydramine hydrochloride 30 MG [Vetadryl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310485 | Vetadryl 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310485 | Vetadryl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310485 | Vetadryl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310485 | Vetadryl 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1310487 | ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1310495 | beta-citronellol, (R)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310496 | dimethicone 100 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310497 | povidone K90 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310499 | chlorpheniramine / ibuprofen / phenylephrine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1310500 | chlorpheniramine / ibuprofen / phenylephrine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1310501 | chlorpheniramine / ibuprofen / phenylephrine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1310502 | chlorpheniramine / ibuprofen / phenylephrine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1310503 | chlorpheniramine maleate 4 MG / ibuprofen 200 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310503 | chlorpheniramine maleate 4 MG / ibuprofen 200 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 131051 | Amyloid P component antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131051 | Amyloid P component antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310510 | bisoctrizole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310511 | high fructose corn syrup | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310512 | maltose syrup | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310513 | sorbitan isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310514 | lactoperoxidase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310517 | anchovy preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310519 | Limonia acidissima wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131052 | Prealbumin amyloid antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131052 | Prealbumin amyloid antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310520 | teriflunomide | Full form of descriptor (FN) | YES | |
| RxCUI: 1310520 | teriflunomide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310520 | teriflunomide | Designated preferred name (PT) | YES | |
| RxCUI: 1310520 | teriflunomide | Full form of descriptor (FN) | YES | |
| RxCUI: 1310520 | teriflunomide | Designated preferred name (PT) | YES | |
| RxCUI: 1310521 | teriflunomide 14 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310522 | teriflunomide Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1310522 | teriflunomide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1310522 | teriflunomide Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1310523 | teriflunomide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1310524 | teriflunomide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1310525 | teriflunomide 14 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1310525 | teriflunomide 14 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310525 | teriflunomide 14 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1310525 | teriflunomide 14 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310526 | Aubagio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1310527 | teriflunomide 14 MG [Aubagio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310528 | teriflunomide Oral Tablet [Aubagio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1310529 | Aubagio Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 131053 | 3-alpha-17-beta-Dihydroxy-5-alpha-androstane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131053 | 3-alpha-17-beta-Dihydroxy-5-alpha-androstane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131053 | 3-alpha-17-beta-Dihydroxy-5-alpha-androstane | Designated preferred name (PT) | NO | |
| RxCUI: 131053 | 3-alpha-17-beta-Dihydroxy-5-alpha-androstane | Full form of descriptor (FN) | NO | |
| RxCUI: 1310530 | Aubagio Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1310531 | Aubagio 14 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310531 | Aubagio 14 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310531 | Aubagio 14 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310532 | teriflunomide 7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310533 | teriflunomide 7 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1310533 | teriflunomide 7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310533 | teriflunomide 7 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1310533 | teriflunomide 7 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310534 | teriflunomide 7 MG [Aubagio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310535 | Aubagio 7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310535 | Aubagio 7 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310535 | Aubagio 7 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310536 | sodium polyacrylate (2500000 MW) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310537 | undecyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310538 | trihydroxystearin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310539 | di(4-tert-butylcyclohexyl) peroxydicarbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310540 | acetylcarnitine, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1310541 | D&C red no. 21 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310542 | butylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310542 | butylene glycol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310543 | 1,3-dimethylol-5,5-dimethylhydantoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310544 | aminomethylpropanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310544 | aminomethylpropanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310545 | Acesulfame potassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310545 | Acesulfame potassium | Designated preferred name (PT) | YES | |
| RxCUI: 1310545 | Acesulfame potassium | Full form of descriptor (FN) | YES | |
| RxCUI: 1310545 | Acesulfame potassium | Designated preferred name (PT) | YES | |
| RxCUI: 1310545 | Acesulfame potassium | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310545 | Acesulfame potassium | Full form of descriptor (FN) | YES | |
| RxCUI: 1310546 | acesulfame | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310548 | alkyl (C12-15) benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310549 | trisodium citrate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310550 | butane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310551 | Stearic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310551 | Stearic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1310551 | Stearic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1310551 | Stearic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1310551 | Stearic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1310551 | Stearic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310551 | Stearic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310553 | zinc stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310554 | triethyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310555 | stearalkonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310557 | methylparaben sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310558 | FD & C red no. 40 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310559 | D&C red no. 27 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310562 | FD &C yellow #6 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310563 | D & C red # 30 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310564 | D&C red no. 7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310565 | ethylcellulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310565 | ethylcellulose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310566 | magnesium silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310567 | magnesium stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310568 | methyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310568 | methyl alcohol | Designated preferred name (PT) | YES | |
| RxCUI: 1310568 | methyl alcohol | Full form of descriptor (FN) | YES | |
| RxCUI: 1310568 | methyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310568 | methyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310568 | methyl alcohol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310569 | sodium laureth-3 sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310569 | sodium laureth-3 sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310570 | laureth-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310571 | shea butter | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310572 | ferric oxide red | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310572 | ferric oxide red | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310573 | croscarmellose sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310574 | croscarmellose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310575 | FD&C red no. 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310576 | corn syrup | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310578 | Medium chain triglycerides | Designated preferred name (PT) | YES | |
| RxCUI: 1310578 | Medium chain triglycerides | Full form of descriptor (FN) | YES | |
| RxCUI: 1310578 | Medium chain triglycerides | Designated preferred name (PT) | YES | |
| RxCUI: 1310578 | Medium chain triglycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310578 | Medium chain triglycerides | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310578 | Medium chain triglycerides | Full form of descriptor (FN) | YES | |
| RxCUI: 1310579 | butyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310580 | methyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310581 | menthyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310582 | hydrogenated palm glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310583 | methylcellulose (100 CPS) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1310584 | Laminaria digitata preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310585 | phenyl trimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310586 | octyltriethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310587 | skim milk | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310588 | {10 (12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet) / 10 (12 HR clonidine hydrochloride 0.2 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1310588 | {10 (12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet) / 10 (12 HR clonidine hydrochloride 0.2 MG Extended Release Oral Tablet) } Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310589 | Kapvay Extended Release Oral Tablet Dose Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1310589 | Kapvay Extended Release Oral Tablet Dose Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1310589 | Kapvay Extended Release Oral Tablet Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310589 | Kapvay Extended Release Oral Tablet Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310593 | D&C red no. 22 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310593 | D&C red no. 22 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310593 | D&C red no. 22 | Designated preferred name (PT) | YES | |
| RxCUI: 1310593 | D&C red no. 22 | Full form of descriptor (FN) | YES | |
| RxCUI: 1310593 | D&C red no. 22 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310593 | D&C red no. 22 | Designated preferred name (PT) | YES | |
| RxCUI: 1310593 | D&C red no. 22 | Full form of descriptor (FN) | YES | |
| RxCUI: 1310594 | Macrogol 4000 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310594 | Macrogol 4000 | Full form of descriptor (FN) | YES | |
| RxCUI: 1310594 | Macrogol 4000 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310594 | Macrogol 4000 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310594 | Macrogol 4000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310594 | Macrogol 4000 | Designated preferred name (PT) | YES | |
| RxCUI: 1310594 | Macrogol 4000 | Designated preferred name (PT) | YES | |
| RxCUI: 1310594 | Macrogol 4000 | Full form of descriptor (FN) | YES | |
| RxCUI: 1310598 | polyethylene glycol 600 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310599 | carbomer copolymer type A (allyl pentaerythritol crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310599 | carbomer copolymer type A (allyl pentaerythritol crosslinked) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310600 | Allura red AC dye | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310601 | D.C. red no. 33 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310602 | diazolidinylurea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310603 | oleyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310605 | brilliant blue FCF | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310627 | chlorpheniramine maleate 4 MG / dextromethorphan HBr 12.5 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310627 | chlorpheniramine maleate 4 MG / dextromethorphan HBr 12.5 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310627 | chlorpheniramine maleate 4 MG / dextromethorphan HBr 12.5 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310635 | Osteo Bi-Flex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1310636 | chondroitin sulfates 200 MG / glucosamine hydrochloride 250 MG [Osteo Bi-Flex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310637 | chondroitin sulfates / glucosamine Oral Tablet [Osteo Bi-Flex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1310638 | Osteo Bi-Flex Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1310639 | Osteo Bi-Flex Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1310640 | Osteo Bi-Flex 250 MG / 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310640 | Osteo Bi-Flex 250 MG / 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310640 | Osteo Bi-Flex 250 MG / 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310641 | Rhulicort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310642 | hydrocortisone acetate 5 MG/ML [Rhulicort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310643 | hydrocortisone Topical Cream [Rhulicort] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310644 | Rhulicort Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310645 | hydrocortisone acetate 5 MG/ML Topical Cream [Rhulicort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310645 | hydrocortisone acetate 5 MG/ML Topical Cream [Rhulicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310645 | hydrocortisone acetate 5 MG/ML Topical Cream [Rhulicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310647 | apple pectin 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310648 | apple pectin / Lactobacillus acidophilus Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1310649 | apple pectin 20 MG / Lactobacillus acidophilus 200 Million UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310649 | apple pectin 20 MG / Lactobacillus acidophilus 200 Million UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310649 | apple pectin 20 MG / Lactobacillus acidophilus 200 Million UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310653 | Lactobacillus rhamnosus GG 1.5 Billion Cells Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310653 | Lactobacillus rhamnosus GG 1.5 Billion Cells Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 131066 | Antigen of Avastrovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131066 | Antigen of Avastrovirus | Full form of descriptor (FN) | NO | |
| RxCUI: 131066 | Antigen of Avastrovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131066 | Antigen of Avastrovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131066 | Antigen of Avastrovirus | Designated preferred name (PT) | NO | |
| RxCUI: 131067 | Aureobasidium pullulans antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131067 | Aureobasidium pullulans antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 131070 | B lymphocyte antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131070 | B lymphocyte antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310705 | fast green FCF stain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310706 | crospovidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310707 | D&C red no. 28 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310708 | ferrosoferric oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310709 | ceteth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310713 | Tri-zel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310714 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG [Tri-zel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310715 | azelate / cupric oxide / folic acid / niacinamide / pyridoxine / zinc oxide Oral Tablet [Tri-zel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310716 | Tri-zel Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310717 | Tri-zel Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310718 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [Tri-zel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310718 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [Tri-zel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310718 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [Tri-zel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310718 | azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [Tri-zel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310720 | dimethicone 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310720 | dimethicone 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310720 | dimethicone 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310751 | witch hazel 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310752 | witch hazel 0.05 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310752 | witch hazel 0.05 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310752 | witch hazel 0.05 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310753 | inulin 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1310754 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310754 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310754 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310816 | RevitaDERM Wound Care | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1310817 | benzalkonium chloride 0.001 MG/MG [RevitaDERM Wound Care] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310818 | benzalkonium Topical Gel [RevitaDERM Wound Care] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1310819 | RevitaDERM Wound Care Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1310820 | RevitaDERM Wound Care 0.1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310820 | RevitaDERM Wound Care 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310820 | RevitaDERM Wound Care 0.1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310820 | RevitaDERM Wound Care 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310821 | dimethicone 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310821 | dimethicone 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310821 | dimethicone 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310822 | dimethicone 24.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310823 | dimethicone 2.42 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310823 | dimethicone 2.42 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310823 | dimethicone 2.42 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310826 | dimethicone 10.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1310827 | dimethicone 1.08 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310827 | dimethicone 1.08 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310827 | dimethicone 1.08 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310844 | Bacillus coagulans | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310844 | Bacillus coagulans | Designated preferred name (PT) | YES | |
| RxCUI: 1310844 | Bacillus coagulans | Full form of descriptor (FN) | YES | |
| RxCUI: 1310845 | Lactobacillus helveticus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310846 | Proteus inconstans | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310848 | Aphanizomenon flos-aquae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1310903 | Proteus mirabilis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310905 | Trichophyton verrucosum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310907 | Mycobacterium phlei | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310908 | Brevibacterium stationis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310909 | Propionibacterium avidum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310910 | Propionibacterium acnes | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310913 | Pseudomonas aeruginosa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310914 | Candida parapsilosis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1310923 | Butorphic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1310924 | butorphanol 10 MG/ML [Butorphic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1310925 | butorphanol Injectable Solution [Butorphic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1310926 | Butorphic Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1310927 | butorphanol 10 MG/ML Injectable Solution [Butorphic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1310927 | butorphanol 10 MG/ML Injectable Solution [Butorphic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310927 | butorphanol 10 MG/ML Injectable Solution [Butorphic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131093 | Extended-spectrum beta lactamase | Designated preferred name (PT) | NO | |
| RxCUI: 131093 | Extended-spectrum beta lactamase | Full form of descriptor (FN) | NO | |
| RxCUI: 1310930 | {10 (chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 10 (methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1310931 | VisRx Dosepack 10 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1310931 | VisRx Dosepack 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310931 | VisRx Dosepack 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310932 | glycerin Soap Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1310933 | glycerin Medicated Bar Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1310934 | glycerin 20 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310934 | glycerin 20 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310934 | glycerin 20 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310939 | mineral oil 50 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1310939 | mineral oil 50 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310939 | mineral oil 50 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 131094 | Beta-2-microglobulin amyloid antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131094 | Beta-2-microglobulin amyloid antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1310942 | {30 (chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 30 (methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1310943 | VisRx Dosepack 30 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1310943 | VisRx Dosepack 30 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310943 | VisRx Dosepack 30 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310944 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1310945 | {10 (chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Oral Tablet) / 10 (methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1310946 | RhinaClear Dose Pack 10 | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1310946 | RhinaClear Dose Pack 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1310948 | calcium 600 MG / vitamin D3 800 UNT Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310948 | calcium 600 MG / vitamin D3 800 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310948 | calcium 600 MG / vitamin D3 800 UNT Oral Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1310948 | calcium 600 MG / vitamin D3 800 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1310950 | calcium carbonate 1500 MG / cholecalciferol 800 UNT [Caltrate Plus D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1310951 | calcium carbonate / cholecalciferol Oral Tablet [Caltrate Plus D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1310954 | Caltrate 600 + D 600 MG / 800 UNT Oral Tablet, as calcium carbonate | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1310954 | Caltrate 600 + D 600 MG / 800 UNT Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1310954 | Caltrate 600 + D 600 MG / 800 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 131100 | Bordetella parapertussis antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131100 | Bordetella parapertussis antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1311039 | Amanita muscaria extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311040 | brown rice preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311041 | Calvatia gigantea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311044 | Epimedium grandiflorum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311047 | immature Juglans regia fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311050 | Oenanthe aquatica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311051 | Picea mariana resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311052 | Quercus robur nut extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311054 | tansy top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311054 | tansy top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311056 | causticum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311057 | Lycopodium clavatum spore extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311058 | brucine sulfate heptahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311059 | brucine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311060 | Mucuna pruriens fruit trichome extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311061 | Klebsiella pneumoniae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311062 | oyster shell calcium carbonate preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311063 | giant puffball extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311064 | barium chloride, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311065 | barium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311066 | Spongia officinalis skeleton extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311067 | Ba - Barium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311067 | Ba - Barium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311067 | Ba - Barium | Designated preferred name (PT) | NO | |
| RxCUI: 1311067 | Ba - Barium | Full form of descriptor (FN) | NO | |
| RxCUI: 1311067 | Ba - Barium | Designated preferred name (PT) | NO | |
| RxCUI: 1311067 | Ba - Barium | Full form of descriptor (FN) | NO | |
| RxCUI: 1311069 | pork brain preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311070 | Lanthanum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311070 | Lanthanum | Designated preferred name (PT) | NO | |
| RxCUI: 1311070 | Lanthanum | Full form of descriptor (FN) | NO | |
| RxCUI: 1311070 | Lanthanum | Designated preferred name (PT) | NO | |
| RxCUI: 1311070 | Lanthanum | Full form of descriptor (FN) | NO | |
| RxCUI: 1311071 | pork liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311072 | barium iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311073 | Cairina moshcata heart-liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311076 | radium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311077 | Claviceps purpurea sclerotium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311078 | porcine pineal gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311078 | porcine pineal gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311079 | Sanguinaria canadensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311079 | Sanguinaria canadensis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311080 | Formica rufa preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311080 | Formica rufa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311081 | cadmium iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311083 | rancid beef preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311084 | choline hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311085 | xanthine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311085 | xanthine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311085 | xanthine | Designated preferred name (PT) | NO | |
| RxCUI: 1311085 | xanthine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311085 | xanthine | Designated preferred name (PT) | NO | |
| RxCUI: 1311089 | Defibrotide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311089 | Defibrotide | Designated preferred name (PT) | YES | |
| RxCUI: 1311089 | Defibrotide | Full form of descriptor (FN) | YES | |
| RxCUI: 1311089 | Defibrotide | Designated preferred name (PT) | YES | |
| RxCUI: 1311089 | Defibrotide | Full form of descriptor (FN) | YES | |
| RxCUI: 1311090 | barium oxalosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311091 | Theridion curassavicum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311092 | Momordica balsamina immature fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311095 | human papillomavirus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311096 | Viscum album fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311098 | Mercurous chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311098 | Mercurous chloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311098 | Mercurous chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311100 | Symphoricarpos albus fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311101 | Sanicula europaea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311102 | Canis lupus familiaris milk preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311103 | ytterbium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311105 | samarium oxide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311107 | neodymium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311109 | Spongia officinalis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311110 | Mercuric cyanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311110 | Mercuric cyanide | Designated preferred name (PT) | NO | |
| RxCUI: 1311110 | Mercuric cyanide | Full form of descriptor (FN) | NO | |
| RxCUI: 1311110 | Mercuric cyanide | Designated preferred name (PT) | NO | |
| RxCUI: 1311110 | Mercuric cyanide | Full form of descriptor (FN) | NO | |
| RxCUI: 1311112 | Bacillus cereus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311114 | lanthanum oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311116 | europium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311117 | mammal liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311118 | gadolinium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311119 | Bacillus subtilis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311121 | Pseudognaphalium obtusifolium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311121 | Pseudognaphalium obtusifolium whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311122 | Triticum aestivum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311123 | Sodium caprylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311123 | Sodium caprylate | Designated preferred name (PT) | YES | |
| RxCUI: 1311123 | Sodium caprylate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311125 | Myrtus communis top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311127 | Ascophyllum nodosum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311128 | Citharacanthus spinicrus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311129 | yeast mannan preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311130 | osmium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311131 | iridium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311133 | Larrea tridenta top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311134 | Propyl gallate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311134 | Propyl gallate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311134 | Propyl gallate | Designated preferred name (PT) | YES | |
| RxCUI: 1311134 | Propyl gallate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311134 | Propyl gallate | Designated preferred name (PT) | YES | |
| RxCUI: 1311137 | acetaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311138 | Sodium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311138 | Sodium bromide | Designated preferred name (PT) | NO | |
| RxCUI: 1311138 | Sodium bromide | Full form of descriptor (FN) | NO | |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1311139 | 2,4-hexadienoic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1311140 | Sorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311140 | Sorbate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311141 | Norsynephrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311141 | Norsynephrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311141 | Norsynephrine | Designated preferred name (PT) | NO | |
| RxCUI: 1311141 | Norsynephrine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311143 | aji pepper extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311144 | Sepia officinalis juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311146 | piperine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311147 | diethylene glycol monoethyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311148 | Lycopus virginicus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311148 | Lycopus virginicus whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311149 | Naphthalin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311149 | Naphthalin | Designated preferred name (PT) | NO | |
| RxCUI: 1311149 | Naphthalin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311149 | Naphthalin | Designated preferred name (PT) | NO | |
| RxCUI: 1311149 | Naphthalin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311149 | Naphthalin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311149 | Naphthalin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311151 | Pulex irritans preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311152 | Hyoscyamus niger extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311153 | dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311153 | dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311154 | Pulsatilla patens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311155 | glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311159 | lead iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311160 | behentrimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311163 | carbomer copolymer type b (allyl pentaerythritol crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311163 | carbomer copolymer type b (allyl pentaerythritol crosslinked) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311164 | carbomer 941 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311164 | carbomer 941 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311164 | carbomer 941 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311165 | glyceryl monostearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311167 | pork kidney preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311170 | beef kidney preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311171 | D&C green no. 5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311171 | D&C green no. 5 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311172 | D & C red no. 27 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311176 | D&C red no. 30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311177 | gonorrheal urethral secretion human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311178 | D&C red no. 6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311179 | isopropyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311186 | lauramidopropyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311188 | Anemone pulsatilla extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311188 | Anemone pulsatilla extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311190 | Au - Gold | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311190 | Au - Gold | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311190 | Au - Gold | Designated preferred name (PT) | YES | |
| RxCUI: 1311190 | Au - Gold | Full form of descriptor (FN) | YES | |
| RxCUI: 1311190 | Au - Gold | Designated preferred name (PT) | YES | |
| RxCUI: 1311190 | Au - Gold | Full form of descriptor (FN) | YES | |
| RxCUI: 1311192 | bovine joint capsule preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311192 | bovine joint capsule preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311193 | Corallium rubrum exoskeleton preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311197 | Laricifomes officinalis fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311199 | porcine small intestine mucosa lymph follicle preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311199 | porcine small intestine mucosa lymph follicle preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311202 | Super Spot Remover | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311203 | salicylic acid 0.02 MG/MG [Super Spot Remover] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311204 | salicylic acid Topical Gel [Super Spot Remover] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311205 | Super Spot Remover Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311206 | Super Spot Remover 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311206 | Super Spot Remover 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311206 | Super Spot Remover 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311206 | Super Spot Remover 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311207 | porcine artery preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311207 | porcine artery preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311210 | porcine vein preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311210 | porcine vein preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311212 | porcine brainstem preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311212 | porcine brainstem preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Designated preferred name (PT) | NO | |
| RxCUI: 1311214 | 5-hydroxy tryptamine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311215 | porcine brain preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311215 | porcine brain preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311216 | cupric acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311217 | Proclearz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311218 | tolnaftate 10 MG/ML [Proclearz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311219 | tolnaftate Topical Solution [Proclearz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311220 | Proclearz Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311221 | ProClearz 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311221 | ProClearz 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311221 | ProClearz 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311221 | ProClearz 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311223 | porcine thalamus lateral geniculate nucleus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311223 | porcine thalamus lateral geniculate nucleus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311224 | indole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311225 | IL-3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311225 | IL-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311225 | IL-3 | Designated preferred name (PT) | NO | |
| RxCUI: 1311225 | IL-3 | Full form of descriptor (FN) | NO | |
| RxCUI: 1311225 | IL-3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311226 | porcine bile duct preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311226 | porcine bile duct preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311228 | Morganella morganii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311229 | porcine ileum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311229 | porcine ileum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311230 | disodium hydrogen phosphate dehydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311232 | porcine oral mucosa preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311232 | porcine oral mucosa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311234 | porcine gallbladder preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311234 | porcine gallbladder preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311235 | porcine adrenal gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311235 | porcine adrenal gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311236 | ethylenediamine tetra (methylene phosphonic acid) monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311238 | orotic acid monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311240 | porcine hypothalamus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311240 | porcine hypothalamus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311241 | porcine pituitary gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311241 | porcine pituitary gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311242 | porcine stomach preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311242 | porcine stomach preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311243 | silicic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311244 | porcine limbic system preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311244 | porcine limbic system preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311245 | porcine nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311245 | porcine nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311246 | daikon extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311246 | daikon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311247 | porcine ankle joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311247 | porcine ankle joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311248 | porcine cartilage preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311248 | porcine cartilage preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311249 | porcine frontal lobe preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311249 | porcine frontal lobe preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311250 | porcine hip joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311250 | porcine hip joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311251 | porcine hippocampus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311251 | porcine hippocampus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311252 | porcine joint capsule preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311252 | porcine joint capsule preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311253 | porcine lymph preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311253 | porcine lymph preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311254 | porcine mesenchyme preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311254 | porcine mesenchyme preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311255 | porcine erythrocyte preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311255 | porcine erythrocyte preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311256 | porcine solar plexus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311256 | porcine solar plexus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311257 | porcine spinal cord preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311257 | porcine spinal cord preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311258 | porcine sympathetic nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311258 | porcine sympathetic nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311259 | magnesium sulfate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311260 | maltose monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311261 | Maltose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311261 | Maltose | Designated preferred name (PT) | YES | |
| RxCUI: 1311261 | Maltose | Full form of descriptor (FN) | YES | |
| RxCUI: 1311262 | porcine tendon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311262 | porcine tendon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311263 | porcine thymus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311263 | porcine thymus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311264 | porcine tonsil preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311264 | porcine tonsil preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311265 | Cantharis preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311265 | Cantharis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311266 | porcine vagus nerve preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311266 | porcine vagus nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311268 | porcine colon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311268 | porcine colon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311269 | porcine renal pelvis preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311269 | porcine renal pelvis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311271 | Guaiacum sanctum resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311272 | porcine blood preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311272 | porcine blood preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311273 | scandium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311274 | porcine bone preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311274 | porcine bone preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311275 | Staphylococcus aureus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311276 | porcine bone marrow preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311276 | porcine bone marrow preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311278 | mercurio sulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311278 | mercurio sulfide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311279 | palladium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311280 | platinum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311281 | Streptococcus pyogenes | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311282 | zinc sulfate, heptahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311283 | mercurous iodide preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311285 | ersofermin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311286 | monobasic sodium phosphate, dihydrate | Designated preferred name (PT) | YES | |
| RxCUI: 1311286 | monobasic sodium phosphate, dihydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311286 | monobasic sodium phosphate, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311287 | Thyrocalcitonin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311287 | Thyrocalcitonin | Designated preferred name (PT) | NO | |
| RxCUI: 1311287 | Thyrocalcitonin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311287 | Thyrocalcitonin | Designated preferred name (PT) | NO | |
| RxCUI: 1311287 | Thyrocalcitonin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311287 | Thyrocalcitonin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311287 | Thyrocalcitonin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311288 | Mephitis mephitis anal gland fluid preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311289 | Lactuca virosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311289 | Lactuca virosa whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311289 | Lactuca virosa whole extract | Designated preferred name (PT) | NO | |
| RxCUI: 1311289 | Lactuca virosa whole extract | Full form of descriptor (FN) | NO | |
| RxCUI: 1311289 | Lactuca virosa whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131129 | Calcitonin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131129 | Calcitonin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311291 | Danio rerio egg preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311292 | chromium gluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311293 | Ferrum phosphoricum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311293 | Ferrum phosphoricum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311294 | potassium carbonate 1 1/2 hydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311295 | benzene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311296 | ferrous iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311297 | gold trichloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311298 | sodium carbonate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311299 | IL-10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311299 | IL-10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311299 | IL-10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311299 | IL-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311299 | IL-10 | Designated preferred name (PT) | NO | |
| RxCUI: 1311299 | IL-10 | Full form of descriptor (FN) | NO | |
| RxCUI: 1311301 | porcine heart preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311302 | Ononis spinosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311302 | Ononis spinosa whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311304 | calcium hexafluorosilicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311305 | Taraxacum officinale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311307 | Peptostreptococcus anaerobius | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311308 | strontium carbonate preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311309 | salsolinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311310 | Primula veris extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311311 | sodium dihydrogen phosphate dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311312 | sodium hypophosphite monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311313 | sodium hypophosphite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311314 | ferric picrate preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311315 | porcine capillary tissue preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311315 | porcine capillary tissue preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311316 | porcine cerebellum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311316 | porcine cerebellum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311317 | porcine cerebral cortex preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311317 | porcine cerebral cortex preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311318 | Lonicera xylosteum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311319 | porcine collagen preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311319 | porcine collagen preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311319 | porcine collagen preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 131132 | Campylobacter jejuni antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131132 | Campylobacter jejuni antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1311320 | porcine conjunctiva preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311320 | porcine conjunctiva preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311321 | porcine corpus luteum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311321 | porcine corpus luteum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311322 | porcine bronchus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311322 | porcine bronchus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311323 | sodium phosphate, dibasic, dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311324 | porcine diencephalon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311324 | porcine diencephalon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311325 | porcine duodenum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311325 | porcine duodenum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311326 | sodium phosphate, dibasic, dodecahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311327 | porcine embryo preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311327 | porcine embryo preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311328 | porcine esophagus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311328 | porcine esophagus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311329 | porcine jejunum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311329 | porcine jejunum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311330 | porcine lung preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311330 | porcine lung preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311332 | porcine mammary gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311332 | porcine mammary gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311334 | porcine nasal mucosa preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311334 | porcine nasal mucosa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311336 | porcine ovary preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311336 | porcine ovary preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311337 | porcine pancreas preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311337 | porcine pancreas preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311338 | porcine placenta preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311338 | porcine placenta preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311340 | porcine prostate preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311340 | porcine prostate preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311341 | porcine pylorus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311341 | porcine pylorus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311342 | sodium phosphate, dibasic, monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311343 | porcine rectum preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311343 | porcine rectum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311344 | porcine spleen preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311344 | porcine spleen preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311345 | sodium phosphate, tribasic, dodecahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311346 | porcine superior gastric plexus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311346 | porcine superior gastric plexus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311347 | porcine temporal lobe preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311347 | porcine temporal lobe preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311348 | porcine parathyroid gland preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311348 | porcine parathyroid gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311349 | porcine testicle preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311349 | porcine testicle preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311350 | porcine thalamus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311350 | porcine thalamus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311354 | porcine tooth preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311354 | porcine tooth preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311355 | porcine umbilical cord preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311355 | porcine umbilical cord preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311356 | porcine ureter preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311356 | porcine ureter preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311357 | sodium phosphate, tribasic, monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311358 | porcine urethra preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311358 | porcine urethra preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311359 | porcine urinary bladder preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311359 | porcine urinary bladder preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311360 | porcine uterus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311360 | porcine uterus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311361 | porcine eye preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311361 | porcine eye preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311362 | sodium potassium tartrate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311363 | potassium sodium tartrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311365 | porcine intervertebral disc preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311365 | porcine intervertebral disc preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311366 | porcine achilles tendon preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311366 | porcine achilles tendon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311367 | porcine knee joint preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311367 | porcine knee joint preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311368 | Plantago major extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311369 | sodium succinate hexahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311370 | sodium succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311371 | stannous fluoride dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311372 | trehalose dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311373 | trehalose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311374 | Gardenia jasminoides fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311375 | kerosene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311376 | Chamaemelum nobile extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311377 | potassium silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311378 | xylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311379 | sulfur iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311380 | IL-11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311380 | IL-11 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311380 | IL-11 | Designated preferred name (PT) | NO | |
| RxCUI: 1311380 | IL-11 | Full form of descriptor (FN) | NO | |
| RxCUI: 1311380 | IL-11 | Designated preferred name (PT) | NO | |
| RxCUI: 1311380 | IL-11 | Full form of descriptor (FN) | NO | |
| RxCUI: 1311381 | toluene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311384 | tellurium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311385 | sinusitisinum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311386 | 3-methylindole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311386 | 3-methylindole | Designated preferred name (PT) | NO | |
| RxCUI: 1311386 | 3-methylindole | Full form of descriptor (FN) | NO | |
| RxCUI: 1311387 | chlorogenic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311388 | holmium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311389 | gallic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311390 | Santonin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311390 | Santonin | Designated preferred name (PT) | NO | |
| RxCUI: 1311390 | Santonin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311391 | nitric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311392 | porcine intestine preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311392 | porcine intestine preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311392 | porcine intestine preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311393 | amber | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311396 | magnesium ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311397 | caffeic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311398 | Lobelia | Designated preferred name (PT) | NO | |
| RxCUI: 1311398 | Lobelia | Full form of descriptor (FN) | NO | |
| RxCUI: 1311398 | Lobelia | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311399 | Drimia maritima bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311402 | rhodium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311404 | Larix decidua resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311406 | Sorghum bicolor subsp. bicolor pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311406 | Sorghum bicolor subsp. bicolor pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311407 | Sb - Antimony | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311407 | Sb - Antimony | Designated preferred name (PT) | NO | |
| RxCUI: 1311407 | Sb - Antimony | Full form of descriptor (FN) | NO | |
| RxCUI: 1311407 | Sb - Antimony | Designated preferred name (PT) | NO | |
| RxCUI: 1311407 | Sb - Antimony | Full form of descriptor (FN) | NO | |
| RxCUI: 1311407 | Sb - Antimony | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311410 | maitake extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311411 | Anemone americana extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311413 | chloroacetate Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1311414 | chloroacetate Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1311415 | chloroacetate 800 MG/ML Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311416 | Monocete | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311417 | chloroacetate 800 MG/ML [Monocete] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311418 | chloroacetate Medicated Pad [Monocete] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311419 | Monocete Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311420 | Monocete Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311421 | chloroacetate 800 MG/ML Medicated Pad [Monocete] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311421 | chloroacetate 800 MG/ML Medicated Pad [Monocete] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311421 | chloroacetate 800 MG/ML Medicated Pad [Monocete] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311421 | chloroacetate 800 MG/ML Medicated Pad [Monocete] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311475 | mercuric sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311476 | bromine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311477 | Chondrus crispus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311478 | carbon disulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311479 | frankincense extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311480 | neodymium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311481 | praseodymium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311482 | dysprosium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311483 | erbium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311484 | europium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311485 | cetyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311488 | copovidone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311488 | copovidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311489 | rubidium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311490 | tantalum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311494 | ambergris | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311495 | sodium fluoride f-18 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311496 | thulium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311497 | Melissa officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311497 | Melissa officinalis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311498 | ytterbium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311499 | sea salt | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311500 | mebrofenin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311501 | Rosa canina fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311503 | benzoyl peroxide 5.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311503 | benzoyl peroxide 5.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311503 | benzoyl peroxide 5.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311504 | Aluminum element | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311504 | Aluminum element | Full form of descriptor (FN) | YES | |
| RxCUI: 1311504 | Aluminum element | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311504 | Aluminum element | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311504 | Aluminum element | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311504 | Aluminum element | Designated preferred name (PT) | YES | |
| RxCUI: 1311504 | Aluminum element | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311504 | Aluminum element | Designated preferred name (PT) | YES | |
| RxCUI: 1311504 | Aluminum element | Full form of descriptor (FN) | YES | |
| RxCUI: 1311505 | ammonium glycyrrhizate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311505 | ammonium glycyrrhizate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 1311506 | Enoxolone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311506 | Enoxolone-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 1311506 | Enoxolone-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 1311506 | Enoxolone-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Designated preferred name (PT) | NO | |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Full form of descriptor (FN) | NO | |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311507 | 4-methylbenzylidene camphor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311508 | Origanum vulgare subsp. hirtum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311509 | Paullinia cupana seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311510 | Petroselinum crispum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311511 | Peucedanum ostruthium leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311512 | Pfaffia paniculata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311516 | benzyl chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311517 | bismuth oxychloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311519 | carnitine chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311520 | Ceftiofur monohydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311520 | Ceftiofur monohydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311520 | Ceftiofur monohydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311520 | Ceftiofur monohydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311521 | Ceftiofur | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311521 | Ceftiofur | Designated preferred name (PT) | YES | |
| RxCUI: 1311521 | Ceftiofur | Full form of descriptor (FN) | YES | |
| RxCUI: 1311521 | Ceftiofur | Designated preferred name (PT) | YES | |
| RxCUI: 1311521 | Ceftiofur | Full form of descriptor (FN) | YES | |
| RxCUI: 1311523 | menthol 15 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311523 | menthol 15 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311523 | menthol 15 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311524 | Aspartamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311524 | Aspartamine | Designated preferred name (PT) | YES | |
| RxCUI: 1311524 | Aspartamine | Full form of descriptor (FN) | YES | |
| RxCUI: 1311524 | Aspartamine | Designated preferred name (PT) | YES | |
| RxCUI: 1311524 | Aspartamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311524 | Aspartamine | Full form of descriptor (FN) | YES | |
| RxCUI: 1311525 | cetrimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311526 | calcium silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311527 | cetylpyridinium chloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311527 | cetylpyridinium chloride anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1311527 | cetylpyridinium chloride anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1311528 | cocamidopropyl propylene glycol-dimonium chloride phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311528 | cocamidopropyl propylene glycol-dimonium chloride phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311529 | Coffea arabica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311530 | ethanolamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311531 | European elderberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311532 | glycine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311533 | Lithium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311533 | Lithium chloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311533 | Lithium chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311534 | tromethamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311535 | TRI-LINYAH 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1311535 | TRI-LINYAH 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1311535 | TRI-LINYAH 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311537 | methylene chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311538 | Angelica keiskei top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311539 | magnesium chloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311540 | hexamethyldisiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311541 | Aronia melanocarpa fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311542 | Ornithine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311542 | Ornithine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311542 | Ornithine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311543 | Hibiscus sabdariffa calyx extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311544 | methylephedrine hydrochloride, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311545 | N-methylephedrine | Designated preferred name (PT) | NO | |
| RxCUI: 1311545 | N-methylephedrine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311545 | N-methylephedrine | Designated preferred name (PT) | NO | |
| RxCUI: 1311545 | N-methylephedrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311545 | N-methylephedrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311545 | N-methylephedrine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311546 | Hippophae rhamnoides fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311547 | Hordeum vulgare top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311548 | 4-hydroxyproline | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311548 | 4-hydroxyproline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311548 | 4-hydroxyproline | Designated preferred name (PT) | YES | |
| RxCUI: 1311548 | 4-hydroxyproline | Full form of descriptor (FN) | YES | |
| RxCUI: 1311548 | 4-hydroxyproline | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311549 | Aronia melanocarpa fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311550 | distearyldimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311551 | Lilium candidum bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311552 | distearyldimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311553 | robenidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311553 | robenidine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1311553 | robenidine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1311554 | robenidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311554 | robenidine | Designated preferred name (PT) | NO | |
| RxCUI: 1311554 | robenidine | Full form of descriptor (FN) | NO | |
| RxCUI: 1311555 | nitarsone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311555 | nitarsone | Designated preferred name (PT) | NO | |
| RxCUI: 1311555 | nitarsone | Full form of descriptor (FN) | NO | |
| RxCUI: 1311556 | nonoxynol-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311557 | Benincasa hispida fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311558 | nonoxynol-100 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311559 | nonoxynol-30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311560 | norflurane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311561 | holy basil top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311561 | holy basil top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311562 | Bidens bipinnata top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311563 | n-Pentane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311563 | n-Pentane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311563 | n-Pentane | Designated preferred name (PT) | NO | |
| RxCUI: 1311563 | n-Pentane | Full form of descriptor (FN) | NO | |
| RxCUI: 1311564 | candelilla wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311565 | beta-propiolactone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311565 | beta-propiolactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311566 | Salinomycin | Full form of descriptor (FN) | YES | |
| RxCUI: 1311566 | Salinomycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311566 | Salinomycin | Designated preferred name (PT) | YES | |
| RxCUI: 1311566 | Salinomycin | Full form of descriptor (FN) | YES | |
| RxCUI: 1311566 | Salinomycin | Designated preferred name (PT) | YES | |
| RxCUI: 1311567 | sulisobenzone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311568 | carnuba wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311569 | tetrofosmin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311570 | cetyl esters wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311571 | ethyl vanillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311572 | decyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Designated preferred name (PT) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Designated preferred name (PT) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Full form of descriptor (FN) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Full form of descriptor (FN) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311573 | Citrus aurantium extract | Designated preferred name (PT) | YES | |
| RxCUI: 1311573 | Citrus aurantium extract | Full form of descriptor (FN) | YES | |
| RxCUI: 1311574 | Sodium propyl para-hydroxybenzoate | Designated preferred name (PT) | YES | |
| RxCUI: 1311574 | Sodium propyl para-hydroxybenzoate | Full form of descriptor (FN) | YES | |
| RxCUI: 1311574 | Sodium propyl para-hydroxybenzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311574 | Sodium propyl para-hydroxybenzoate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311575 | C13-14 isoparaffin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311576 | Cocamidopropylbetaine (in water) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311576 | Cocamidopropylbetaine (in water) | Designated preferred name (PT) | YES | |
| RxCUI: 1311576 | Cocamidopropylbetaine (in water) | Full form of descriptor (FN) | YES | |
| RxCUI: 1311576 | Cocamidopropylbetaine (in water) | Full form of descriptor (FN) | YES | |
| RxCUI: 1311577 | Crataegus monogyna fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311579 | Tribulus terrestris fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311580 | Cullen corylifolium fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311581 | Zanthoxylum piperitum fruit pulp extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311582 | nifurpipone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311583 | nicarbazin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311583 | nicarbazin | Designated preferred name (PT) | NO | |
| RxCUI: 1311583 | nicarbazin | Full form of descriptor (FN) | NO | |
| RxCUI: 1311584 | Cymbopogon schoenanthus top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311585 | metomidate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311586 | Pinus massoniana resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311588 | sodium glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311589 | Empetrum nigrum fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311590 | Forsythia suspensa fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311591 | Fritillaria przewalskii bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311592 | benzododecinium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311593 | benzododecinium | Designated preferred name (PT) | NO | |
| RxCUI: 1311593 | benzododecinium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311593 | benzododecinium | Full form of descriptor (FN) | NO | |
| RxCUI: 1311593 | benzododecinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311594 | Lauralkonium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311594 | Lauralkonium bromide | Designated preferred name (PT) | YES | |
| RxCUI: 1311594 | Lauralkonium bromide | Full form of descriptor (FN) | YES | |
| RxCUI: 1311594 | Lauralkonium bromide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311595 | Garcinia gummi-gutta fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311595 | Garcinia gummi-gutta fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311596 | Gleditsia sinensis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311597 | Lysozyme hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311597 | Lysozyme hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 1311597 | Lysozyme hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1311598 | Hamamelis virginiana top water extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311599 | abetimus sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311600 | abetimus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311601 | Hedera helix top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311602 | 3,7-dimethyloctanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311603 | acetyltriethyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311604 | Hippophae rhamnoides fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311605 | Codium tomentosum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311606 | amyl cinnamal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311608 | Hovenia dulcis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311609 | croscarmellose sodium type A | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311610 | chaga fruiting body extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311610 | chaga fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311611 | avocado oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311611 | avocado oil | Designated preferred name (PT) | YES | |
| RxCUI: 1311611 | avocado oil | Full form of descriptor (FN) | YES | |
| RxCUI: 1311612 | Ipomoea purpurea top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311613 | glycereth-18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311614 | methyl trimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311615 | Kigelia africana fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311616 | ethylhexyl methoxycrylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311617 | octyldodecyl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311618 | lemon peel wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311619 | cetomacrogol 1000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311619 | cetomacrogol 1000 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311620 | ceteareth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311621 | ceteareth-15 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311622 | ceteareth-25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311623 | ceteareth-30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311624 | ceteareth-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311625 | magnesium sulfate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311625 | magnesium sulfate anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1311625 | magnesium sulfate anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1311625 | magnesium sulfate anhydrous | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311626 | paroxetine hydrochloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311626 | paroxetine hydrochloride anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1311626 | paroxetine hydrochloride anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1311626 | paroxetine hydrochloride anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1311627 | Limonium vulgare flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311628 | cupric arsenite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311629 | nickel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311630 | lowbush blueberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311631 | strontium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311632 | Lycium barbarum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311633 | thallium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311634 | Bichloride of mercury | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311634 | Bichloride of mercury | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311634 | Bichloride of mercury | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311634 | Bichloride of mercury | Designated preferred name (PT) | NO | |
| RxCUI: 1311634 | Bichloride of mercury | Full form of descriptor (FN) | NO | |
| RxCUI: 1311634 | Bichloride of mercury | Designated preferred name (PT) | NO | |
| RxCUI: 1311634 | Bichloride of mercury | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311634 | Bichloride of mercury | Full form of descriptor (FN) | NO | |
| RxCUI: 1311635 | Lycium chinense fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311636 | Mahonia aquifolium fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311637 | anisacril | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311638 | capryl methicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311639 | acetic monoethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311640 | tallow acid, beef | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311641 | noni fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311641 | noni fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311642 | noni fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311642 | noni fruit juice | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311643 | Morus nigra fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311645 | Myrciaria dubia fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311646 | Narcissus tazetta bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311647 | orange peel wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311648 | Panax ginseng fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311650 | ultramarine blue | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311651 | Passiflora incarnata fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311653 | Perilla frutescens fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311654 | Phyllanthus emblica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311655 | hydrolyzed placental protein (bovine) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311656 | Phyllanthus niruri top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311658 | pomegranate fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311659 | bee propolis extact | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311659 | bee propolis extact | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311660 | ammonium lactate 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1311660 | ammonium lactate 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311660 | ammonium lactate 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1311661 | ammonium lactate 50 MG/ML [Geri-Hydrolac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1311662 | Geri-Hydrolac 5 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1311662 | Geri-Hydrolac 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1311662 | Geri-Hydrolac 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311662 | Geri-Hydrolac 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311663 | Prunus mume fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311664 | Prunus serotina fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311665 | Brassica rapa var. rapa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311666 | Pyracantha fortuneana fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311667 | Rosa multiflora fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311668 | Rosa roxburghii fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311669 | pimagedine HCl | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311669 | pimagedine HCl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311670 | pimagedine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311671 | Rubus chamaemorus fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311672 | indeloxazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1311673 | indeloxazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311674 | Sapindus mukorossi fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311675 | Schisandra chinensis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311676 | ractopamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311677 | ractopamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311678 | glyceryl monooleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1311678 | glyceryl monooleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311681 | Scutellaria lateriflora top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311682 | star anise fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311683 | Terminalia chebula fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311684 | Tetradium ruticarpum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311685 | Vaccinium myrtillus fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311686 | Vitex trifolia fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311687 | Xanthium strumarium fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311688 | Zanthoxylum armatum var. armatum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311689 | glycerol formal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311690 | glyceryl distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311691 | glyceryl dilaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311692 | glyceryl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1311693 | glyceryl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311694 | glyceryl cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311695 | glyceryl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311743 | deslorelin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1311744 | deslorelin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311744 | deslorelin | Designated preferred name (PT) | YES | |
| RxCUI: 1311744 | deslorelin | Full form of descriptor (FN) | YES | |
| RxCUI: 1311745 | deslorelin 4.7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1311746 | deslorelin Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1311747 | deslorelin Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1311748 | deslorelin acetate 4.7 MG subcutaneous Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311748 | deslorelin acetate 4.7 MG subcutaneous Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311749 | Suprelorin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311750 | deslorelin 4.7 MG [Suprelorin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311751 | deslorelin Drug Implant [Suprelorin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311752 | Suprelorin Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311753 | Suprelorin F 4.7 MG Subcutaneous Drug Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311753 | Suprelorin F 4.7 MG Subcutaneous Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311753 | Suprelorin F 4.7 MG Subcutaneous Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311753 | Suprelorin F 4.7 MG Subcutaneous Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 131178 | Choriogonadotrophin antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131178 | Choriogonadotrophin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131178 | Choriogonadotrophin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311787 | Zostrix Cold Therapy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311788 | menthol 40 MG/ML [Zostrix Cold Therapy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311789 | menthol Topical Cream [Zostrix Cold Therapy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 131179 | Chromogranin A antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131179 | Chromogranin A antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311790 | Zostrix Cold Therapy Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311791 | Zostrix Cold Therapy 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311791 | Zostrix Cold Therapy 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311791 | Zostrix Cold Therapy 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311791 | Zostrix Cold Therapy 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311792 | chloroxylenol 0.015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1311793 | chloroxylenol 1.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311793 | chloroxylenol 1.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311793 | chloroxylenol 1.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311794 | Hooflex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1311795 | chloroxylenol 0.015 MG/MG [Hooflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311796 | chloroxylenol Topical Ointment [Hooflex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311797 | Hooflex Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1311798 | HOOFLEX 1.5 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311798 | HOOFLEX 1.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311798 | HOOFLEX 1.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311798 | HOOFLEX 1.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311799 | chloroxylenol 1.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311799 | chloroxylenol 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311799 | chloroxylenol 1.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 131180 | Chromogranin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131180 | Chromogranin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311800 | chloroxylenol 15 MG/ML [Hooflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1311801 | chloroxylenol Topical Solution [Hooflex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1311802 | HOOFLEX 1.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1311802 | HOOFLEX 1.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311802 | HOOFLEX 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311802 | HOOFLEX 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311803 | witch hazel 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1311804 | witch hazel 0.06 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311804 | witch hazel 0.06 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311804 | witch hazel 0.06 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1311807 | capsaicin 0.033 % Topical Cream (28.3 GM) / menthol 4 % Topical Cream (28.3 GM) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1311807 | capsaicin 0.033 % Topical Cream (28.3 GM) / menthol 4 % Topical Cream (28.3 GM) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311810 | ZOSTRIX HOT and COLD THERAPY SYSTEM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311810 | ZOSTRIX HOT and COLD THERAPY SYSTEM Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1311810 | ZOSTRIX HOT and COLD THERAPY SYSTEM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1311810 | ZOSTRIX HOT and COLD THERAPY SYSTEM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1311811 | alpha-hexylcinnamaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1311817 | cultivated mushroom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 131182 | Chymotrypsin antigen | Designated preferred name (PT) | NO | |
| RxCUI: 131182 | Chymotrypsin antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1311820 | {10 (12 HR chlorpheniramine maleate 4 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 10 (12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) } Pack [RespiVent DF Dosepack 10] | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1311824 | Allergy DN II Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1311824 | Allergy DN II Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131185 | Clostridium difficile antibody | Designated preferred name (PT) | NO | |
| RxCUI: 131185 | Clostridium difficile antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1312084 | Yucca glauca root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312085 | Convallaria majalis bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312086 | TEA-lactate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1312086 | TEA-lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 131222 | Antigen of Cryptosporidium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131222 | Antigen of Cryptosporidium | Full form of descriptor (FN) | NO | |
| RxCUI: 131222 | Antigen of Cryptosporidium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 131222 | Antigen of Cryptosporidium | Designated preferred name (PT) | NO | |
| RxCUI: 1312260 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312260 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312260 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312261 | Derma Numb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312262 | lidocaine hydrochloride 40 MG/ML [Derma Numb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312263 | lidocaine Topical Spray [Derma Numb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312264 | Derma Numb Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312265 | DERMA NUMB 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312265 | DERMA NUMB 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312265 | DERMA NUMB 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312265 | DERMA NUMB 4 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312266 | Anthelban V | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1312267 | pyrantel 50 MG/ML [Anthelban V] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312268 | pyrantel Oral Suspension [Anthelban V] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312269 | Anthelban V Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312270 | Anthelban V Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312271 | pyrantel 50 MG/ML Oral Suspension [Anthelban V] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312271 | pyrantel 50 MG/ML Oral Suspension [Anthelban V] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312274 | sulfadimethoxine 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1312275 | sulfadimethoxine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1312276 | sulfadimethoxine 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312277 | sulfadimethoxine 50 MG/ML [Albon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1312278 | sulfadimethoxine Oral Suspension [Albon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1312279 | Albon Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1312280 | Albon 250 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312280 | Albon 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312280 | Albon 250 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312280 | Albon 250 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1312283 | camphor 3 % / menthol 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1312283 | camphor 3 % / menthol 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312283 | camphor 3 % / menthol 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1312357 | (C10-C30)alkyl methacrylate ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312358 | Aldosterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312358 | Aldosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1312358 | Aldosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1312358 | Aldosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1312358 | Aldosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1312359 | Androsterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312359 | Androsterone | Designated preferred name (PT) | NO | |
| RxCUI: 1312359 | Androsterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1312360 | C10-18 triglycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312361 | cetearyl isononanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312362 | chloromethyl methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312363 | chromium hydroxide green | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1312365 | Chrysanthellum indicum flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312366 | citric acid acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312367 | dehydroacetic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312368 | trideceth-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312369 | Tussilago farfara extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312370 | human sputum, Bordetella pertussis infected | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312371 | Thujopsis dolabrata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312372 | Thujopsis dolabrata leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312373 | tetrasodium glutamate diacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312374 | salsolinol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1312375 | influenza A virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312376 | influenza B virus whole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312376 | influenza B virus whole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1312377 | Magnolia kobus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312378 | Rubus chamaemorus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312379 | Hexaplex trunculus hypobranchial gland juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312380 | Atropa belladonna fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312381 | phosphoramidic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312382 | Quercus rubra bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312383 | Quercus alba extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312384 | measles virus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1312385 | calcium behenate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1312387 | dimethicone-diene dimethicone crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1312388 | melanin synthetic (tyrosine, peroxide) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally |